Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Montero

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Antimicrobial Agents and Chemotherapy|November 13, 2019
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological PatientsCarlota Gudiol, Montserrat Arnan, Manuela Aguilar-Guisado, et al.
Blood|May 15, 2025
Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24Eman Khatib-Massalha, Christian Andrea Di Buduo, Agathe L Chédeville, et al.
Antibiotics (Basel, Switzerland)|February 12, 2021
Long-Term Impact of an Educational Antimicrobial Stewardship Program on Management of Patients with Hematological DiseasesAna Belén Guisado-Gil, Manuela Aguilar-Guisado, Germán Peñalva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2019
Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) PolymorphismsEstrella Carrillo-Cruz, José R García-Lozano, Francisco J Márquez-Malaver, et al.
Frontiers in Pharmacology|December 12, 2019
Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia PatientsBeatriz Colom-Fernández, Anna Kreutzman, Ana Marcos-Jiménez, et al.
The Lancet. Haematology|November 21, 2017
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trialManuela Aguilar-Guisado, Ildefonso Espigado, Almudena Martín-Peña, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Antimicrobial Agents and Chemotherapy|November 13, 2019
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological PatientsCarlota Gudiol, Montserrat Arnan, Manuela Aguilar-Guisado, et al.
Blood|May 15, 2025
Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24Eman Khatib-Massalha, Christian Andrea Di Buduo, Agathe L Chédeville, et al.
Antibiotics (Basel, Switzerland)|February 12, 2021
Long-Term Impact of an Educational Antimicrobial Stewardship Program on Management of Patients with Hematological DiseasesAna Belén Guisado-Gil, Manuela Aguilar-Guisado, Germán Peñalva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2019
Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) PolymorphismsEstrella Carrillo-Cruz, José R García-Lozano, Francisco J Márquez-Malaver, et al.
Frontiers in Pharmacology|December 12, 2019
Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia PatientsBeatriz Colom-Fernández, Anna Kreutzman, Ana Marcos-Jiménez, et al.
The Lancet. Haematology|November 21, 2017
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trialManuela Aguilar-Guisado, Ildefonso Espigado, Almudena Martín-Peña, et al.
Pageof 5